Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003

The British Journal of Dermatology
A L Cowden, K A Katz

Abstract

Spending on advertising of prescription medicines in the U.S.A. is increasing by nearly a billion dollars yearly. The Food and Drug Administration (FDA) is legally mandated to regulate pharmaceutical advertising in the U.S.A. Prior studies have documented inaccuracies in pharmaceutical advertisements, in the U.S.A. and the rest of the world. To assess trends in FDA surveillance of dermatology-related prescription drug advertising, and to investigate pharmaceutical companies' responses to FDA regulatory actions. We analysed all FDA citations of prescription drug advertisements issued during 2000-2003, and responses from cited companies to our mailed requests for follow-up information. Twenty-four dermatology-related drugs from 21 companies accounted for 30 (15.2%) of the 198 letters sent by the FDA; of these, 18 letters cited advertisements or promotions of these medications for dermatology-related uses. The most common violation cited overall was insufficient communication of risk (32.4% overall, 33.9% dermatology-related). Most FDA letters cited physician-targeted advertising (71.6% overall, 62.1% dermatology-related). The number of dermatology-related letters sent declined by 69.2% from 2000 (n=13) to 2003 (n=4), paralleling ...Continue Reading

References

Jun 1, 1992·Annals of Internal Medicine·M S WilkesM F Shapiro
Jun 1, 1992·Annals of Internal Medicine·D A Kessler
Dec 1, 1991·Statistics in Medicine·D G Altman
May 8, 1991·JAMA : the Journal of the American Medical Association·D Rennie
Jul 1, 1982·The American Journal of Medicine·J AvornR Hartley
Jan 31, 1980·The New England Journal of Medicine·B GastelJ A Brody
Aug 1, 1995·Journal of General Internal Medicine·M S Wilkes, R L Kravitz
Jul 1, 1994·Journal of the American Academy of Dermatology·J E Angel
Jan 1, 1993·International Journal of Health Services : Planning, Administration, Evaluation·A HerxheimerB Westerholm
Jun 1, 1993·Journal of the American Academy of Dermatology·D J HoganJ Kramer
Nov 26, 1999·Journal of General Internal Medicine·R A BellM S Wilkes
Sep 13, 2002·The Medical Journal of Australia·Tim W LokeJeanette E Ward
Jan 9, 2003·Lancet·Robert H Fletcher
Jan 9, 2003·Lancet·Pilar VillanuevaInmaculada Pereiró
Feb 28, 2003·International Journal of Impotence Research·B B Garber
Apr 24, 2003·Journal of General Internal Medicine·Richelle J CooperMichael S Wilkes
May 31, 2003·BMJ : British Medical Journal·James J Oliver, Simon R Maxwell
Jul 10, 2003·The Journal of Bone and Joint Surgery. American Volume·Timothy BhattacharyyaThomas A Einhorn
Dec 4, 2003·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·R J HinchliffeUNKNOWN Zenith Users Group
Jun 24, 2004·Journal of Molecular Biology·Ekaterina I ZagryadskayaSergey V Steinberg
Jul 2, 2004·Lancet Neurology·Marilynn Larkin
Jul 22, 2004·Journal of Palliative Medicine·Steven K DobschaLinda Ganzini
Jul 24, 2004·The Orthopedic Clinics of North America·Marvin E Steinberg, David R Steinberg
Oct 16, 2004·Pharmacoepidemiology and Drug Safety·Kari S LankinenArja Helin-Salmivaara
Jan 1, 2005·BMJ : British Medical Journal·Peter R MansfieldLes Toop
Jan 1, 2005·BMJ : British Medical Journal·Jeanne Lenzer
Jan 15, 2005·Annals of the New York Academy of Sciences·Simone Fulda, Klaus-Michael Debatin
Jan 22, 2005·The New England Journal of Medicine·Eve E Slater
Jan 28, 2005·The New England Journal of Medicine·Ernst R Berndt
Jan 29, 2005·Annals of the New York Academy of Sciences·Kenneth G WaltonRobert H Schneider
Feb 1, 2005·Annals of the New York Academy of Sciences·Shengzhou Wu, Steven W Barger
Mar 11, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Blenda A Chao
Mar 15, 2005·Journal of Health Communication·Kimberly A KaphingstLawren H Daltroy
Apr 20, 2005·Annals of the New York Academy of Sciences·Juan S Bonifacino
Apr 23, 2005·BMJ : British Medical Journal·Joe Collier
Apr 28, 2005·JAMA : the Journal of the American Medical Association·Richard L KravitzPeter Franks
Apr 28, 2005·JAMA : the Journal of the American Medical Association·Matthew F Hollon
May 4, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jenny H Zheng
Jun 25, 2005·Surgery Today·David S FinleyDavid K Imagawa
Sep 1, 2005·Archives of Disease in Childhood. Fetal and Neonatal Edition·D J Henderson-SmartUNKNOWN Australian and New Zealand Neonatal Network
Sep 1, 2005·Journal of Pediatric Gastroenterology and Nutrition·Marion RowlandBrendan Drumm

❮ Previous
Next ❯

Citations

Jun 20, 2006·Journal of the American Academy of Dermatology·Cynthia L Bartus, Kenneth A Katz
Nov 10, 2015·Current Addiction Reports·Marion S Greene, R Andrew Chambers
Jun 7, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Cynthia BrennanShabir Somani
Dec 21, 2018·Digestive Diseases and Sciences·M Rubayat RahmanHemant Goyal
Jun 17, 2010·Journal of Wound Care·F GottrupUNKNOWN European Wound Management Association Patient Outcome Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.